CRSP — CRISPR THERAPEUTICS AG CHF0.03 Common Stock

Ownership history in Rathbones Group PLC  ·  1 quarter on record

This page tracks every 13F SEC filing in which Rathbones Group PLC reported a position in CRISPR THERAPEUTICS AG CHF0.03 Common Stock (CRSP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 INITIATED 3,097 — — 0.00% $201K $64.81
% of Fund (quarterly)    CRSP price (monthly, adj. close)

Other funds also holding CRSP

As of 2025 Q4 — sorted by position size

GSK plc 21.14% SR ONE CAPITAL MANAGEMENT, LP 3Y 15.14% Versant Venture Management, LLC 3Y 7Y 5.17% ARK Investment Management LLC 3Y 7Y 3.66% EcoR1 Capital, LLC 3Y 7Y 3.31% NEA Management Company, LLC 3Y 7Y 2.83% Green Alpha Advisors, LLC 3Y 2.68% Stonepine Capital Management, LLC 3Y 7Y 1.91% IQ EQ FUND MANAGEMENT (IRELAND) Ltd 3Y 7Y 1.41% Orbis Allan Gray Ltd 3Y 7Y 1.31%
← Back to Rathbones Group PLC Holdings